BMCMI
ELOS

Bryn Mawr Capital Management Inc’s Syneron Medical Ltd ELOS Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-26,399
Closed -$230K – 666
2013
Q2 		$230K Buy
+26,399
New +$236K 0.02% 422

Other funds holding ELOS

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HC
Hourglass Capital Houston, Texas $508M AUM 32.5% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bryn Mawr Capital Management Inc's ELOS Position: Q3 2013 in Review

Bryn Mawr Capital Management Inc sold out of Syneron Medical Ltd (ELOS) in Q3 2013, closing a stake of 26,399 shares — an estimated $230K sold.

Bryn Mawr Capital Management Inc first reported a position in ELOS in Q2 2013 and held it in 1 quarter. The position peaked at $230K in Q2 2013. 58 funds tracked by Wall St. Rank hold ELOS as of Q3 2013.

  • Bryn Mawr Capital Management Inc reported no remaining Syneron Medical Ltd position as of Q3 2013 after selling out during the quarter.
  • Bryn Mawr Capital Management Inc sold 26,399 Syneron Medical Ltd shares in Q3 2013, an estimated $230K.
  • Bryn Mawr Capital Management Inc first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 1 quarter.
  • Bryn Mawr Capital Management Inc's Syneron Medical Ltd position peaked at $230K in Q2 2013.
  • 58 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2013.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q3 2013, filed 14 Nov 2013.